From Petri Dish to Patient: Organoids Advance Personalized Cancer Treatment
In the relentless quest to decode the complexities of cancer, a transformative model is emerging — patient-derived tumor organoids (PDOs). ...
In the relentless quest to decode the complexities of cancer, a transformative model is emerging — patient-derived tumor organoids (PDOs). ...
A groundbreaking study led by researchers at the University of Birmingham, in collaboration with the University of Turku in Finland, ...
In a groundbreaking advance that promises to transform the landscape of precision oncology, Altuna Akalin and his research team at ...
In the relentless battle against cancer, understanding the intricate evolutionary dynamics of tumors remains a formidable challenge. A groundbreaking study ...
In the dynamic realm of oncology, the advent of targeted radionuclide therapy (TRT) marks a paradigm shift that fuses precision ...
In the relentless pursuit of advanced cancer therapeutics, antibody–drug conjugates (ADCs) have carved a significant niche due to their ability ...
In a landmark advancement for the treatment of limited-stage small cell lung cancer (LS-SCLC), researchers at the National Cancer Center ...
In a groundbreaking development poised to accelerate lung cancer research, the 23andMe Research Institute, in collaboration with Troper Wojcicki Philanthropies ...
In a groundbreaking development in the fight against non-small cell lung cancer (NSCLC), researchers have unveiled promising results from a ...
New Advances from Memorial Sloan Kettering Spark Hope for Cancer Patients Worldwide Recent groundbreaking research emerging from Memorial Sloan Kettering ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine